rs547125345

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_017882.3(CLN6):​c.53C>T​(p.Ala18Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00023 in 1,466,042 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00013 ( 1 hom. )

Consequence

CLN6
NM_017882.3 missense

Scores

2
3
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:3

Conservation

PhyloP100: 0.135
Variant links:
Genes affected
CLN6 (HGNC:2077): (CLN6 transmembrane ER protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007166922).
BP6
Variant 15-68229532-G-A is Benign according to our data. Variant chr15-68229532-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 193389.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=4}. Variant chr15-68229532-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00111 (169/152098) while in subpopulation AFR AF= 0.00395 (164/41548). AF 95% confidence interval is 0.00345. There are 1 homozygotes in gnomad4. There are 87 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLN6NM_017882.3 linkc.53C>T p.Ala18Val missense_variant Exon 1 of 7 ENST00000249806.11 NP_060352.1 Q9NWW5-1A0A024R601
CLN6NM_001411068.1 linkc.180-10882C>T intron_variant Intron 1 of 6 NP_001397997.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLN6ENST00000249806.11 linkc.53C>T p.Ala18Val missense_variant Exon 1 of 7 1 NM_017882.3 ENSP00000249806.5 Q9NWW5-1
ENSG00000260007ENST00000562767.2 linkc.53C>T p.Ala18Val missense_variant Exon 1 of 3 3 ENSP00000456336.1 H3BRN7

Frequencies

GnomAD3 genomes
AF:
0.00111
AC:
168
AN:
151990
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00393
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000958
GnomAD3 exomes
AF:
0.000149
AC:
12
AN:
80350
Hom.:
0
AF XY:
0.000109
AC XY:
5
AN XY:
45976
show subpopulations
Gnomad AFR exome
AF:
0.00632
Gnomad AMR exome
AF:
0.0000624
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000236
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000343
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000128
AC:
168
AN:
1313944
Hom.:
1
Cov.:
31
AF XY:
0.000110
AC XY:
71
AN XY:
647796
show subpopulations
Gnomad4 AFR exome
AF:
0.00450
Gnomad4 AMR exome
AF:
0.0000744
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000260
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000124
Gnomad4 OTH exome
AF:
0.000277
GnomAD4 genome
AF:
0.00111
AC:
169
AN:
152098
Hom.:
1
Cov.:
34
AF XY:
0.00117
AC XY:
87
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.00395
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000948
Alfa
AF:
0.00139
Hom.:
0
Bravo
AF:
0.00134
ExAC
AF:
0.000275
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jan 08, 2017
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 17, 2016
Athena Diagnostics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Uncertain:1
Aug 03, 2020
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.A18V variant (also known as c.53C>T), located in coding exon 1 of the CLN6 gene, results from a C to T substitution at nucleotide position 53. The alanine at codon 18 is replaced by valine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and valine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Feb 23, 2025
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 30019023) -

Adult neuronal ceroid lipofuscinosis;C5551375:Ceroid lipofuscinosis, neuronal, 6A Uncertain:1
May 23, 2017
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

CLN6-related disorder Benign:1
Aug 22, 2019
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Neuronal ceroid lipofuscinosis Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
.;T;T;T;T;T;.;.
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.82
T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0072
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.16
T
MutationAssessor
Benign
1.4
.;L;.;.;.;.;.;.
PrimateAI
Pathogenic
0.80
T
PROVEAN
Uncertain
-3.9
D;N;N;N;.;.;N;.
REVEL
Benign
0.22
Sift
Benign
0.22
.;T;D;T;.;.;T;.
Sift4G
Pathogenic
0.0
D;T;D;T;.;.;T;.
Polyphen
0.16
.;B;.;.;.;.;.;.
Vest4
0.086
MVP
0.50
MPC
0.086
ClinPred
0.023
T
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.044
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs547125345; hg19: chr15-68521870; API